VIVEVE MEDICAL INC (VIVE) Stock Analyst Ratings
NASDAQ:VIVE - Nasdaq - US92852W5013 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to VIVE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.77. This target is 2066.52% above the current price.
VIVE was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about VIVE.
In the previous month the buy percentage consensus was at a similar level.
VIVE was analyzed by 8 analysts. More opinions would make the average more meaningful.